GVR Report cover Tendonitis Treatment Market Size, Share & Trends Report

Tendonitis Treatment Market Size, Share & Trends Analysis Report By Treatment, By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Swimmer's Shoulder), By Region, And Segment Forecasts, 2021 - 2028

  • Report ID: GVR-4-68039-530-4
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2019
  • Industry: Healthcare

Report Overview 

The global tendonitis treatment market size was valued at USD 190.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 2.8% from 2021 to 2028. Increasing incidence of tendonitis due to growth in the aging population, sports and occupational work injuries, and sudden injuries caused due to physical exercise and trauma is likely to propel market growth over the forecast period. In addition, increasing use of electronic devices among children and teenagers makes them highly susceptible to hands, arms, and wrist-related problems, thereby increasing the chances of developing tendonitis. Also, as per the Bureau of Labor Statistics, more than 70,000 individuals tend to miss their work annually due to tendonitis. However, the recurrent nature of sudden injuries, treatment-associated side effects, and prolonged inactivity are recommended rest, causing stiff joints are some of the factors restraining market growth.

U.S. tendonitis treatment market size, by treatment, 2018 - 2028 (USD Billion)

The increasing incidence of sports-related injuries owing to the rapid increase in sports activities is the leading cause of soft tissue injuries worldwide and a main impact-rendering driver for the market. Moreover, growing career opportunities and rising inclination towards healthy fitness have increased the number of individuals adopting sports as a career or a hobby. It, in turn, is projected to increase their chances of incurring injuries. According to a study published by a group of sports medicine professors from the University of Virginia and Duke University, approximately 40.0% to 50.0% of the competitive runners have been witnessed to suffer from Achilles tendinopathy.

The increasing incidence of tendonitis in the general population accounting for approximately 5-10 cases per 100,000 individuals is further expected to drive the market for tendonitis treatment. Moreover, the growing penetration of various treatment options such as physical therapy, over-the-counter drugs for pain management, and different surgical procedures has increased the number of individuals undergoing treatment, thereby aiding the market growth. Among these, physical therapy has proved to be the first-line treatment for tendonitis because eccentric strengthening has been considered a very effective treatment for various chronic tendon conditions.

The tendon in the human body is a highly aligned connective tissue that allows the transmission of force from muscles to bone. On average, over 32.0 million tendon injuries have been reported every year. Tendinopathies account for 50.0% of all sports-related injuries, with increasing incidence rates over the last decade due to the aging population. Currently used clinical grafts in tendon treatment are subjected to various restrictions and there is a significant demand for alternative engineered tissue. Owing to this, it is an aggressive need for innovative strategies such as tendon replacement and regeneration to sustain market growth.

COVID19 Tendonitis treatment market impact: 3.4% decline in revenue growth from 2019 to 2020

Pandemic Impact

Post COVID Outlook

The market decreased by 3.4% from 2019 to 2020

The market is estimated to witness a year-on-year growth of approximately 2.0% to 2.6% in the next five years.

Factors, such as shortage of Personal Protective Equipment (PPE) and trained workforce and restrictions and lockdowns forced the healthcare facilities to reschedule and prioritize procedures as essential or nonessential. During the pandemic, several physical therapies and surgical procedures for tendonitis treatment were not considered essential, which can be attributed to a decline in market growth during the pandemic.

The healthcare facilities are focused on developing strategies to restart elective surgeries such as septic disorders and traumatic tendon injuries once the pandemic stabilizes. Moreover, management of delayed tendonitis-related trauma and sudden injuries is going to be a key task by the majority of healthcare facilities.

The pandemic affected manufacturing, supply chains, product distribution, operations, and other business activities, of the key players. Various companies operating in the market have reported a decline in sales of their products meant for tendonitis treatment.

The healthcare facilities and various elbow and shoulder surgeons worldwide are evaluating their perception of emergency, and are actively focused to predict the “new normal” with changed priority order for treatment procedures in the forthcoming post-COVID scenario, thereby providing affirmative growth prospects in the upcoming years.


Furthermore, increasing investments in R&D, geographic expansions, collaborations with other industry players, and product differentiation are among the key strategies adopted by key companies for gaining a competitive edge in the market. In January 2017, Orthocell Limited - a regenerative medicine company entered into a research collaboration agreement with the DePuy Synthes to promote its Ortho-ATI stem cell approach meant for regeneration of degenerated ligaments and tendons. 

Treatment Insights

In 2020, the therapy treatment segment dominated the market for tendonitis treatment and accounted for the largest revenue share of 73.4%. It is attributed to the increasing preference for non-invasive therapies over surgical procedures for tendonitis treatment by target patients. Among the therapy segment, physical therapy accounted for the largest market share on the account of being the first line of treatment. Moreover, other therapy types, including hot and cold therapy and shockwave therapy, have been witnessing significant growth in their demand over the past few years.

In addition, apart from physical therapy, NSAIDs are also given as preliminary treatment for tendinitis. In case of severe damage to tendons that can't be treated with pharmacological treatments, surgery is considered the last option for tendonitis treatment. Cold therapy, including cold compresses, on the other hand, is usually effective during the first 48 hours of injury. The treatment options for tendonitis varies with a different type of indications. The most common form of tendonitis is Achilles Tendonitis, with the Achilles tendon being the largest tendon in the human body.

Condition Insights

In 2020, the Achilles tendonitis segment dominated the market owing to the rising occurrence in sports players and athletes. As per the NCBI article titled 'Biomedical Risk Factors of Achilles Tendinopathy in Physically Active People' stated, the cumulative lifetime incidence of injury for Achilles Tendonitis is estimated to be approximately 24.0% in athletes in 2021. In addition, it has been reported that elite adolescent athletes have a frequency of 1.0% - 2.0% for Achilles tendinopathy, whereas the frequency of injury was reported to be 9.0% in recreational athletes. The treatment of Achilles tendonitis includes both conservative and surgical procedures that vary for acute or chronic conditions. In the case of individuals with a full rupture, the surgical treatment procedure is highly recommended by the specialists.

Global tendonitis treatment market share, by condition, 2020 (%)

The golfer’s elbow segment is anticipated to grow at the fastest rate over the forecast period, owing to the rising prevalence of medial elbow tendinopathy and lateral elbow tendinopathy. An NCBI article on Golfer’s elbow published in May 2018, stated that a golfer’s elbow commonly occurs between the ages of 40-60 years and affects both males and females at the same rate. Therefore, the growing geriatric population and changing lifestyles, transitioning towards physical and sporting activities, eventually contributes to the growth of elbow tendinopathy, driving the segment.

Regional Insights

Asia Pacific dominated the market for tendonitis treatment and accounted for the largest revenue share of 69.7% in 2020 owing to the growing number of tendonitis surgeries performed in the region and rising disposable income. Increasing penetration of local manufacturers of medical devices and growing target population has resulted in significant growth opportunities for the tendonitis treatment market in the region. Furthermore, the other key factors driving the market are ongoing research in this field, increasing products in the pipeline for tendonitis treatment, particularly in China and Japan, coupled with an increasing number of sports-related injuries.

However, Lain America is anticipated to register the fastest CAGR of 3.3% during the forecast period. The presence of a large number of medical centers and hospitals in Latin America performing surgical procedures and therapies for tendonitis is one of the key reasons supporting market growth. Several highly reputable surgeons, physicians, and medical experts from various other countries have aligned in regional hospitals in Latin America in order to create cutting-edge treatment protocols focused on patient-centric quality care.

Key Companies & Market Share Insights

High presence of well-established and small domestic and globally operating players has been a key impacting factor driving the market for tendonitis treatment. The majority of companies are undergoing multiple partnerships and mergers and acquisitions to increase their product portfolio and to expand their product reach. For instance, in June 2018, Orthocell announced positive results obtained from a study performed on its Ortho-ATI - a new tendon cell therapy treatment intended to treat tennis elbow. This study was expected to bolster the tendonitis treatment innovative therapy segment’s growth, as well as shoulder and elbow segments. Some of the prominent players in the tendonitis treatment market include:

  • Merck and Co., Inc.

  • AstraZeneca

  • Boehringer Ingelheim Pharmaceuticals, Inc.

  • Abbott

  • Pfizer

  • Bayer AG

  • GlaxoSmithKline PLC

  • Almatica Pharma, Inc.

  • Teva Pharmaceuticals Industries

Tendonitis Treatment Market Report Scope

Report Attribute


Market size value in 2021

USD 193.9 billion

Revenue forecast in 2028

USD 235.4 billion

Growth Rate

CAGR of 2.8% from 2021 to 2028

Base year for estimation


Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million and CAGR from 2021 to 2028

Report coverage

Revenue, company ranking, competitive landscape, growth factors, and trends

Segments covered

Treatment, condition, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Germany; U.K.; Spain; Italy; France; Russia; Japan; China; India; Singapore; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE

Key companies profiled

Merck and Co., Inc.; Bayer AG; AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; Abbott; Pfizer; GlaxoSmithKline PLC; Almatica Pharma, Inc.; Teva Pharmaceuticals Industries

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global tendonitis treatment market report on the basis of treatment, condition, and region:

  • Treatment Outlook (Revenue, USD Million, 2016 - 2028)

    • Therapy

      • Hot and Cold Therapy

      • Physical Therapy

      • Shockwave Therapy

    • Surgery

  • Condition Outlook (Revenue, USD Million, 2016 - 2028)

    • Tennis Elbow

    • Golfer’s Elbow

    • Pitcher’s Elbow

    • Jumper’s Knee

    • Swimmer’s Shoulder

    • Achilles Tendonitis

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • Spain

      • Italy

      • France

      • Russia

    • Asia Pacific

      • Japan

      • China

      • India

      • Singapore

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • MEA

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report




This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.